The Potential of Human Peptide LL-37 as an Antimicrobial and Anti-Biofilm Agent
The rise in antimicrobial resistant bacteria threatens the current methods utilized to treat bacterial infections. The development of novel therapeutic agents is crucial in avoiding a post-antibiotic era and the associated deaths from antibiotic resistant pathogens. The human antimicrobial peptide L...
Saved in:
Main Authors: | Kylen E. Ridyard (Author), Joerg Overhage (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Synergy between Human Peptide LL-37 and Polymyxin B against Planktonic and Biofilm Cells of <i>Escherichia coli</i> and <i>Pseudomonas aeruginosa</i>
by: Kylen E. Ridyard, et al.
Published: (2023) -
Antimicrobial Peptide Loss, Except for LL-37, is not Characteristic of Atopic Dermatitis
by: Lilla Szabó, et al.
Published: (2023) -
Antibacterial and Anti-Inflammatory Properties of a Novel Antimicrobial Peptide Derived from LL-37
by: Haiwei Zhuo, et al.
Published: (2022) -
Long-Lasting Stable Expression of Human LL-37 Antimicrobial Peptide in Transgenic Barley Plants
by: Malihe Mirzaee, et al.
Published: (2021) -
Antimicrobial Properties and Cytotoxicity of LL-37-Derived Synthetic Peptides to Treat Orthopedic Infections
by: Vincenzo Pennone, et al.
Published: (2024)